Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Ruxolitinib cream may help treat severe hair loss in children.

Most children with MIS-C showed significant improvement by 6 months.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

A CCS patient with severe complications was successfully treated using combined therapies.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Cetuximab can cause eyelash growth, which is rare but manageable.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Patients with skin immune diseases need better education on UV protection to improve compliance.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Combining capislow with laser is more effective for reducing unwanted hair, but the effect is temporary.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Apremilast shows promise for several skin conditions but needs more research.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Liposomal IGF-1 safely and effectively treats hair loss in hamsters.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.